Home > Press > AusBiotech supports 'Raising the Bar'
Abstract:
AusBiotech welcomes a legislative Bill that has been introduced into the
Australian Parliament today - The Intellectual Property Laws Amendment
(Raising the Bar) Bill 2011.
AusBiotech supports 'Raising the Bar'
Australia | Posted on June 21st, 2011
AusBiotech confirms its support in general for this package of
intellectual property reform developed by IP Australia and contained in
the 'Raising the Bar' Bill. Specifically, AusBiotech is in favour of a
broad research use exemption from patent infringement becoming enshrined
in Australia's patent law so this country's researchers and industry may
be confident as they strive to innovate.
In its recent submission to the Senate Inquiry into the Patent Amendment
(Human Genes & Biological Materials) Bill 2010, AusBiotech stated its
belief that the thresholds for patentability should be properly set and
rigorously applied across all forms of invention, ie: in a
technology-neutral manner. AusBiotech has publicly and strongly opposed
the Patent Amendment (Human Genes & Biological Materials) Bill 2010, as
it completely fails to address any of the community's valid concerns and
threatens scientific research and development on biological materials.
AusBiotech is instead in favour of the Government's 'Raising the Bar'
Bill which, when taken together with the erudite recommendations from
the Australian Law Reform Commission 1999 report, the Senate Inquiry
into Gene Patents (2010) and the Advisory Council on Intellectual
Property 2010 review will deliver the solutions to address the issues
identified by clinicians, researchers, industry and the community.
AusBiotech strongly encourages the Australian Parliament to support the
Bill so that the many consequential benefits of the law reform can be
effected.
Dr Anna Lavelle, CEO of AusBiotech said: "Two years of consultation and
deliberation that has resulted in the "Raising the Bar' Bill, will
guarantee a strengthening of Australia's IP management system."
####
About AusBiotech
AusBiotech is Australia's voice on biotechnology, and represents more
than 3,000 members, encompassing medicines, medical diagnostics and
devices, agriculture, alternative fuels and climate change.
For more information, please click here
Contacts:
Lorraine Chiroiu
AusBiotech
Communications Manager
03 9828 1414 / 0429 801118
Copyright © AusBiotech
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
News and information
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
Beautiful "flowers" self-assemble in a beaker: Elaborate nanostructures blossom from a chemical reaction perfected at Harvard May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013
Govt.-Legislation/Regulation/Funding/Policy
Beautiful "flowers" self-assemble in a beaker: Elaborate nanostructures blossom from a chemical reaction perfected at Harvard May 17th, 2013
Artificial Forest for Solar Water-Splitting: Berkeley Lab Researchers Report First Fully Integrated Artificial Photosynthesis Nanosystem May 17th, 2013
Moth-Inspired Nanostructures Take the Color Out of Thin Films May 17th, 2013
NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013
Announcements
Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013
NanoInk, Inc. Assets To Be Sold May 18th, 2013
NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013
Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013
Patents/IP/Tech Transfer/Licensing
NanoInk, Inc. Assets To Be Sold May 18th, 2013
HELIOS Program Develops Complete Supply Chain for Integrating Photonics with CMOS Circuit via IC Fabrication Processes May 14th, 2013
Nanotechnology Pioneer Named 'Entrepreneur of the Year': Royal Society of Chemistry honors Chad Mirkin for commercializing innovations May 10th, 2013
Arrowhead Receives Patent Allowance for DPC siRNA Delivery System with Peptide Backbone May 7th, 2013